Thrombolytic therapy for elderly patients

Clinical Trial

E J Topol et al. N Engl J Med. 1992.

. 1992 Jul 2;327(1):45-7.

doi: 10.1056/NEJM199207023270109.

No abstract available

Comment in

The risk of stroke after thrombolytic therapy.
Collins R, Sleight P, Maggioni AP. Collins R, et al. N Engl J Med. 1992 Nov 19;327(21):1531-2. doi: 10.1056/NEJM199211193272116. N Engl J Med. 1992. PMID: 1406889 No abstract available.

The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G. Maggioni AP, et al. N Engl J Med. 1992 Jul 2;327(1):1-6. doi: 10.1056/NEJM199207023270101. N Engl J Med. 1992. PMID: 1598096 Clinical Trial.
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
Krumholz HM, Pasternak RC, Weinstein MC, Friesinger GC, Ridker PM, Tosteson AN, Goldman L. Krumholz HM, et al. N Engl J Med. 1992 Jul 2;327(1):7-13. doi: 10.1056/NEJM199207023270102. N Engl J Med. 1992. PMID: 1598117